The CDKN2A mutants clustered imperfectly when using the panels and these associations are weaker than the very strong correlations between IDH and BRAFV600E mutations and CIMP status in glioma and CRC, respectively. The gene discussed is CDKN2A; the disease is central nervous system cancer.